Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRA1 | P14867 | 3/20 | 0.50 |
| ▸ | GABRG2 | P18507 | 2/20 | 0.50 |
| ▸ | GABRB3 | P28472 | 2/20 | 0.50 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.50 |
| ▸ | LMNA | P02545 | 2/20 | 0.50 |
| ▸ | FAAH | O00519 | 1/20 | 0.50 |
| ▸ | CA1 | P00915 | 1/20 | 0.50 |
| ▸ | CA2 | P00918 | 1/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.50 |
| ▸ | HPGD | P15428 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | GABRB1 | P18505 | 1/20 | 0.50 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.50 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.50 |
| ▸ | HTR2C | P28335 | 1/20 | 0.50 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.50 |
| ▸ | GABRA3 | P34903 | 1/20 | 0.50 |
| ▸ | HTR2B | P41595 | 1/20 | 0.50 |
| ▸ | GABRA2 | P47869 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL243697 | 1.00 | GABRA1 (0.50) | GABRA1GABRG2GABRB3GABRB2LMNA | |
| SCHEMBL5354209 | 1.00 | GABRA1 (0.50) | GABRA1GABRG2GABRB3GABRB2LMNA | |
| SCHEMBL3693753 | 0.98 | GABRA1 (0.48) | GABRA1GABRG2GABRB3GABRB2LMNA | |
| Bromide SCHEMBL9938546 | 0.96 | GABRA1 (0.46) | GABRA1GABRG2GABRB3GABRB2LMNA | |
| Bromide SCHEMBL1576200 | 0.96 | GABRA1 (0.46) | GABRA1GABRG2GABRB3GABRB2LMNA | |
| Hydrochloric Acid SCHEMBL6531420 | 0.96 | GABRA1 (0.46) | GABRA1GABRG2GABRB3GABRB2LMNA | |
| Hydrochloric Acid SCHEMBL6357655 | 0.96 | GABRA1 (0.46) | GABRA1GABRG2GABRB3GABRB2LMNA | |
| SCHEMBL6355270 | 0.94 | GABRA1 (0.45) | GABRA1GABRG2GABRB3GABRB2LMNA | |
| SCHEMBL7053780 | 0.94 | GABRA1 (0.45) | GABRA1GABRG2GABRB3GABRB2LMNA | |
| SCHEMBL13725166 | 0.92 | GABRA1 (0.43) | GABRA1GABRG2GABRB3GABRB2LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 337 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114890856-A | Method for synthesizing 2,2' -biphenyl-1-carboxylic acid derivative | 华南理工大学 | 2022-08-12 | — | — | CN | claimed |
| CN-104302744-A | Corrosion inhibitor compositions for oxygenated gasolines | BUTAMAX TM ADVANCED BIOFUELS | 2015-01-21 | — | — | CN | claimed |
| EP-1363923-B1 | RHODIUM AND IRIDIUM COMPLEXES | MERCK PATENT GMBH (DE) | 2009-04-01 | — | — | EP | claimed |
| US-7125998-B2 | Rhodium and iridium complexes | MERCK PATENT GMBH (DE) | 2006-10-24 | — | — | US | claimed |
| EP-1562964-B1 | PALLADIUM AND PLATINUM COMPLEXES | MERCK PATENT GMBH (DE) | 2006-07-19 | — | — | EP | claimed |
| EP-1521758-B1 | LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION | EXXONMOBIL CHEM PATENTS INC (US) | 2006-05-24 | — | — | EP | claimed |
| US-20040138455-A1 | Rhodium and iridium complexes | MERCK PATENT GMBH (DE) | 2004-07-15 | — | — | US | claimed |
| US-6479422-B1 | CATALYSTS SELECTED FROM THE GROUP CONSISTING OF DIIMINE NICKEL (II) COMPLEXES AND DIIMINE PALLADIUM (II) COMPLEXES | PHILLIPS PETROLEUM COMPANY | 2002-11-12 | — | — | US | claimed |
| US-12635401-B2 | Metal complexes | UDC Ireland (IE) | 2026-05-19 | — | — | US | disclosed |
| US-12631983-B2 | Silica particle, toner for developing electrostatic charge image, electrostatic charge image developer, toner cartridge, process cartridge, image forming apparatus, and image forming method | FUJIFILM BUSINESS INNOVATION CORP. (JP) | 2026-05-19 | — | — | US | disclosed |
| CN-115124043-B | Silica particles and method for producing same | 富士胶片商业创新有限公司 | 2026-05-12 | — | — | CN | disclosed |
| US-20260070936-A1 | METAL COMPLEXES | UDC IRELAND LTD (IE) | 2026-03-12 | — | — | US | disclosed |
| US-12544733-B2 | Gas/liquid oligomerization reactor having successive zones with variable diameters | IFP Energies Nouvelles (FR) | 2026-02-10 | — | — | US | disclosed |
| US-12535752-B2 | Electrostatic charge image developing toner, electrostatic charge image developer, toner cartridge, process cartridge, image forming apparatus, and image forming method | FUJIFILM BUSINESS INNOVATION CORP. (JP) | 2026-01-27 | — | — | US | disclosed |
| EP-0579339-B1 | Fuel products | LUBRIZOL CORP (US) | 1997-06-04 | — | — | EP | disclosed |
| EP-0713519-A1 | ADDITIVE FOR HYDROCARBON OILS | EXXON CHEMICAL PATENTS INC. (US) | 1996-05-29 | — | — | EP | disclosed |
| EP-0482759-B1 | Antiemulsion/antifoam agent for use in oils | LUBRIZOL CORP (US) | 1996-03-27 | — | — | EP | disclosed |
| WO-1995004117-A1 | ADDITIVE FOR HYDROCARBON OILS | EXXON CHEMICAL PATENTS INC. (US) | 1995-02-09 | — | — | WO | disclosed |
| EP-0579339-A1 | Fuel products | The Lubrizol Corporation (US) | 1994-01-19 | — | — | EP | disclosed |
| EP-0482759-A1 | Antiemulsion/antifoam agent for use in oils | The Lubrizol Corporation (US) | 1992-04-29 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12544733-B2 | Gas/liquid oligomerization reactor having successive zones with variable diameters | NOD1, VAT1, DECR1 | GABRA1 2029/4885GABRG2 3100/4885GABRB3 2497/4885 |
| US-20260070936-A1 | METAL COMPLEXES | SCO2, CBR1, CORO1C | GABRA1 692/4885GABRG2 1420/4885GABRB3 1214/4885 |
| US-12635401-B2 | Metal complexes | SCO2, SOD1, NR4A1 | GABRA1 1347/4885GABRG2 1833/4885GABRB3 1105/4885 |
| US-20040138455-A1 | Rhodium and iridium complexes | RPIA, MPI, INPP5B | GABRA1 4094/4885GABRG2 3515/4885GABRB3 4152/4885 |
| US-12631983-B2 | Silica particle, toner for developing electrostatic charge image, electrostatic charge image developer, toner cartridge, process cartridge, image forming apparatus, and image forming method | BET1, SMARCC1, SMARCC2 | GABRA1 984/4885GABRG2 2037/4885GABRB3 1422/4885 |
| US-12535752-B2 | Electrostatic charge image developing toner, electrostatic charge image developer, toner cartridge, process cartridge, image forming apparatus, and image forming method | H1-2, H1-0, CECR2 | GABRA1 3302/4885GABRG2 4143/4885GABRB3 4170/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.